Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
39 | Current Pharmacogenomics and Personalized Medicine | journal | 0.127 Q4 | 20 | 12 | 49 | 613 | 9 | 42 | 0.08 | 51.08 | 54.55 | |
38 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 25 | 71 | 1315 | 56 | 64 | 0.85 | 52.60 | 39.24 | |
37 | Current Drug Therapy | journal | 0.171 Q3 | 20 | 38 | 128 | 2424 | 87 | 124 | 0.40 | 63.79 | 50.30 | |
36 | Drug Metabolism Letters | journal | 0.175 Q3 | 31 | 0 | 24 | 0 | 25 | 23 | 1.04 | 0.00 | 0.00 | |
35 | Anti-Infective Agents | journal | 0.178 Q4 | 26 | 38 | 152 | 2338 | 114 | 146 | 0.61 | 61.53 | 44.62 | |
34 | Current Bioactive Compounds | journal | 0.184 Q3 | 31 | 86 | 291 | 5575 | 253 | 282 | 0.82 | 64.83 | 45.74 | |
33 | Current Pharmaceutical Analysis | journal | 0.184 Q3 | 27 | 63 | 339 | 3875 | 249 | 329 | 0.77 | 61.51 | 54.03 | |
32 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.203 Q4 | 38 | 18 | 53 | 861 | 58 | 50 | 1.07 | 47.83 | 39.36 | |
31 | Letters in Drug Design and Discovery | journal | 0.222 Q3 | 37 | 172 | 329 | 9716 | 360 | 304 | 1.23 | 56.49 | 39.72 | |
30 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.258 Q3 | 45 | 31 | 108 | 1193 | 98 | 103 | 0.85 | 38.48 | 37.50 | |
29 | Current Nanoscience | journal | 0.267 Q3 | 52 | 74 | 228 | 5777 | 388 | 221 | 1.65 | 78.07 | 41.03 | |
28 | Recent Advances in Drug Delivery and Formulation | journal | 0.276 Q3 | 41 | 24 | 48 | 1936 | 71 | 42 | 1.28 | 80.67 | 40.51 | |
27 | Current Computer-Aided Drug Design | journal | 0.283 Q4 | 32 | 36 | 197 | 1766 | 365 | 191 | 1.76 | 49.06 | 38.22 | |
26 | Open Medicinal Chemistry Journal | journal | 0.289 Q3 | 23 | 9 | 22 | 476 | 47 | 19 | 2.80 | 52.89 | 36.36 | |
25 | Combinatorial Chemistry and High Throughput Screening | journal | 0.301 Q3 | 70 | 215 | 504 | 12432 | 828 | 472 | 1.71 | 57.82 | 43.80 | |
24 | Current Drug Discovery Technologies | journal | 0.319 Q3 | 49 | 43 | 184 | 2498 | 326 | 180 | 1.82 | 58.09 | 40.33 | |
23 | Reviews on Recent Clinical Trials | journal | 0.331 Q3 | 35 | 36 | 139 | 1393 | 184 | 123 | 1.51 | 38.69 | 42.86 | |
22 | Medicinal Chemistry | journal | 0.337 Q3 | 50 | 69 | 271 | 5094 | 609 | 265 | 2.05 | 73.83 | 41.48 | |
21 | Infectious Disorders - Drug Targets | journal | 0.338 Q3 | 61 | 89 | 374 | 4320 | 542 | 350 | 1.47 | 48.54 | 42.90 | |
20 | Current Drug Safety | journal | 0.352 Q3 | 41 | 83 | 127 | 2789 | 177 | 124 | 1.10 | 33.60 | 45.66 | |
19 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.356 Q3 | 43 | 24 | 64 | 958 | 90 | 56 | 1.28 | 39.92 | 43.10 | |
18 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.361 Q3 | 27 | 23 | 93 | 1583 | 149 | 88 | 1.15 | 68.83 | 60.40 | |
17 | Current Reviews in Clinical and Experimental Pharmacology | journal | 0.440 Q2 | 49 | 21 | 98 | 1935 | 184 | 92 | 1.29 | 92.14 | 49.25 | |
16 | Recent advances in inflammation & allergy drug discovery | journal | 0.443 Q3 | 37 | 19 | 42 | 1111 | 84 | 35 | 0.86 | 58.47 | 35.14 | |
15 | Current Drug Delivery | journal | 0.451 Q2 | 72 | 108 | 295 | 9600 | 813 | 284 | 2.63 | 88.89 | 44.67 | |
14 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.503 Q3 | 108 | 201 | 723 | 12531 | 2011 | 702 | 2.69 | 62.34 | 40.91 | |
13 | Current Molecular Pharmacology | journal | 0.540 Q3 | 49 | 72 | 209 | 6446 | 509 | 199 | 2.37 | 89.53 | 43.73 | |
12 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.540 Q3 | 52 | 41 | 103 | 3859 | 252 | 100 | 2.51 | 94.12 | 48.44 | |
11 | Current Radiopharmaceuticals | journal | 0.542 Q3 | 32 | 35 | 103 | 1937 | 170 | 92 | 1.29 | 55.34 | 43.71 | |
10 | Current Topics in Medicinal Chemistry | journal | 0.549 Q3 | 133 | 177 | 640 | 18576 | 1720 | 515 | 2.52 | 104.95 | 41.01 | |
9 | Current Pharmaceutical Design | journal | 0.586 Q2 | 183 | 316 | 1278 | 27228 | 3460 | 1174 | 2.55 | 86.16 | 44.50 | |
8 | Mini-Reviews in Medicinal Chemistry | journal | 0.597 Q2 | 107 | 128 | 492 | 14236 | 1903 | 484 | 3.60 | 111.22 | 43.35 | |
7 | CNS and Neurological Disorders - Drug Targets | journal | 0.620 Q2 | 96 | 120 | 223 | 12672 | 632 | 207 | 2.79 | 105.60 | 41.97 | |
6 | Current Cancer Drug Targets | journal | 0.650 Q2 | 103 | 76 | 216 | 5127 | 602 | 211 | 2.34 | 67.46 | 40.55 | |
5 | Current Gene Therapy | journal | 0.674 Q2 | 80 | 33 | 114 | 3190 | 359 | 106 | 3.41 | 96.67 | 40.14 | |
4 | Current Drug Targets | journal | 0.691 Q2 | 119 | 97 | 390 | 10001 | 1214 | 368 | 2.96 | 103.10 | 43.82 | |
3 | Current Medicinal Chemistry | journal | 0.759 Q2 | 202 | 229 | 1117 | 25841 | 4143 | 1046 | 3.54 | 112.84 | 45.47 | |
2 | Current Vascular Pharmacology | journal | 0.991 Q1 | 69 | 47 | 196 | 2887 | 702 | 154 | 2.23 | 61.43 | 41.86 | |
1 | Current Neuropharmacology | journal | 1.299 Q1 | 103 | 177 | 379 | 22198 | 2240 | 363 | 4.96 | 125.41 | 44.80 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®